Tag Archives: castration-resistant
Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer
Great news for patients with advanced prostate cancer. A new investigational agent, abiraterone acetate, was shown to significantly improved survival in men with metastatic castration-resistant prostate cancer. Abiraterone acetate is an investigational agent being developed by Ortho Biotech. It acts … Continue reading
Posted in Cancer, Prostate cancer
Tagged abiraterone, androgen, castration-resistant, CYP17, docetaxel, Ortho Biotech, prednisone, Prostate cancer, Survival
Comments Off on Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer